Medical publication policies and guidelines offer a framework for best practices, but there may be situations when more than one approach seems reasonable. The primary purpose of “What Would You Do?” is to explore examples of such situations. With the limited...
Tomas Rees, PhD, Oxford PharmaGenesis Ltd, Oxford, UK; Stacy Konkiel, MLS/MIS, Altmetric, Farringdon, London, UK; Andrew Shepherd, PhD, Envision Pharma Group, Horsham, UK This article was derived from the efforts of the ISMPP Social Media and Web-based Metrics Working...
An Educational Partnership with the University of Florida College of Pharmacy Hardly a workday goes by that medical publication professionals aren’t faced with the business challenge to communicate the value of a drug to new stakeholders. This rapidly evolving...
Author responsiveness concerns in the wake of the coronavirus disease (COVID-19) global pandemic has resulted in apprehension and numerous inquiries from ISMPP members over the past several weeks. To address these unprecedented circumstances, ISMPP convened a...
Katherine Baria, BSc (ARCS), PhD, AstraZeneca, Gaithersburg, MD, USA; Richard Baker, ISMPP CMPP™, BSc (Hons), Novartis, Basel, Switzerland; Claire Bartlett, ISMPP CMPP™, BA (Hons), CMC Connect, McCann Health Medical Communications, Macclesfield, UK; Belinda Dean,...
